Endometrial prostaglandin f release in vitro and plasma 13, 14-dihydro-15-keto-prostaglandin F2 alpha in pigs with luteolysis blocked by pregnancy, estradiol benzoate or human chorionic gonadotropin.
D000818:Animals; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D003338:Corpus Luteum / Q000187:drug effects / Q000502:physiology*; D015237:Dinoprost / Q000031:analogs & derivatives*; D004717:Endometrium / Q000187:drug effects / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D011247:Pregnancy; D011270:Pregnancy, Animal; D011460:Prostaglandins F / Q000097:blood / Q000378:metabolism*; D013552:Swine / Q000097:blood / Q000378:metabolism* / Q000502:physiology
D006063:Chorionic Gonadotropin; D011460:Prostaglandins F; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D004958:Estradiol; D015237:Dinoprost